Grant opportunity
NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)
This Notice of Funding Opportunity (NOFO) is to encourage applications from investigators to advance the development and translation of next-generation technologies to prevent, monitor, diagnose, and treat disorders within the missions of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) and The Helping to End Addiction Long-term (HEAL) Initiatives. Awarded activities will facilitate the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope of the program includes technology development and optimization, and studies to prepare for approvals for human use.
- Funder
- National Institutes of Health
- Applications close 2030-12-01
- Applications close 2030-12-01: Dec 1, 2030
- Award
- See official notice
- Applicant
- City or township governments; Special district governments; For profit organizations other than small businesses; Small businesses; State governments; Independent school districts; Native American tribal governments (Federally recognized); Public housing authorities/Indian housing authorities; Others (see text field entitled "Additional Information on Eligibility" for clarification); Native American tribal organizations (other than Federally recognized tribal governments); Private institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; County governments; Public and State controlled institutions of higher education
- Discipline
- Health and Biomedical Sciences
- Region
- United States
- Posted
- Oct 27, 2026
Call summary
Overview
NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) is an official Grants.gov notice published between 30 September and 27 October 2026. Opportunity number: RFA-EB-28-004
Who can apply
Eligible applicant types listed by the agency: City or township governments; Special district governments; For profit organizations other than small businesses; Small businesses; State governments; Independent school districts; Native American tribal governments (Federally recognized); Public housing authorities/Indian housing authorities; Others (see text field entitled "Additional Information on Eligibility" for clarification); Native American tribal organizations (other than Federally recognized tribal governments); Private institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; County governments; Public and State controlled institutions of higher education. Applicants must also satisfy every programme-specific condition in the official notice.
What it supports
- This Notice of Funding Opportunity (NOFO) is to encourage applications from investigators to advance the development and translation of next-generation technologies to prevent, monitor, diagnose, and treat disorders within the missions of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) and The Helping to End Addiction Long-term (HEAL) Initiatives. Awarded activities will facilitate the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope of the program includes technology development and optimization, and studies to prepare for approvals for human use.
- Opportunity number: RFA-EB-28-004
Funding and duration
- Award ceiling: See official notice
- Expected number of awards: 4
Applications close 2030-12-01
Applications close 2030-12-01: Dec 1, 2030
How to apply
Open the official Grants.gov record, review the full notice and attachments, and use the application package or agency route stated there.
Call details
Source-based overview
This Notice of Funding Opportunity (NOFO) is to encourage applications from investigators to advance the development and translation of next-generation technologies to prevent, monitor, diagnose, and treat disorders within the missions of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) and The Helping to End Addiction Long-term (HEAL) Initiatives. Awarded activities will facilitate the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope of the program includes technology development and optimization, and studies to prepare for approvals for human use. The official record contains the controlling eligibility, budget, attachment and submission requirements for opportunity RFA-EB-28-004.
Eligibility
Eligible applicant types listed by the agency: City or township governments; Special district governments; For profit organizations other than small businesses; Small businesses; State governments; Independent school districts; Native American tribal governments (Federally recognized); Public housing authorities/Indian housing authorities; Others (see text field entitled "Additional Information on Eligibility" for clarification); Native American tribal organizations (other than Federally recognized tribal governments); Private institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; County governments; Public and State controlled institutions of higher education. Applicants must also satisfy every programme-specific condition in the official notice.
Funding and benefits
Award ceiling: See official notice
Expected number of awards: 4
Themes and supported activities
This Notice of Funding Opportunity (NOFO) is to encourage applications from investigators to advance the development and translation of next-generation technologies to prevent, monitor, diagnose, and treat disorders within the missions of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) and The Helping to End Addiction Long-term (HEAL) Initiatives. Awarded activities will facilitate the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope of the program includes technology development and optimization, and studies to prepare for approvals for human use.
Opportunity number: RFA-EB-28-004
Deadline and timeline
Applications close 2030-12-01: Applications close 2030-12-01: Dec 1, 2030.
Applicants should confirm the exact deadline time, time zone, required documents, portal steps and any institutional approvals on the official call page before submitting.
How to apply
Open the official Grants.gov record, review the full notice and attachments, and use the application package or agency route stated there.
Before applying, check eligibility rules, budgets, attachments, page limits, partner requirements, cost-share conditions and whether the opportunity uses an expression of interest, full proposal, registration or nomination stage.